p52 signaling promotes cellular senescence.

Cell Biosci

Department of Neurological Surgery, The University of Chicago, Chicago, IL, 60637, USA.

Published: April 2022

Background: Nuclear factor-κB is a multi-subunit transcription factor that plays a central role in cellular senescence. We previously reported that an increase in the p52 subunit is seen in senescent cells and aged tissue. In the current work, we examined the mechanism by which p52 is activated and whether the increase in p52 promotes senescence.

Results: Using both primary mouse embryonic fibroblasts (MEFs) and WI-38 human lung fibroblasts, we examined cells after serial passage and following prolonged culture. An increase in p52 was found in the nucleus relative to pre-senescent cells. The increase in p52 protein was not reflected by an increase in NFKB2 mRNA or by an increase in the abundance of upstream activating kinases, IKKα and NIK. To examine whether p52 promotes senescence, we over-expressed mature p52 in primary MEFs. Significantly more senescence was seen compared to control, a finding not seen with p52 mutated at critical DNA binding residues. In addition, blocking p52 nuclear translocation with the peptide inhibitor, SN52, decreased β-galactosidase (β-gal) formation. Subsequent filtration studies demonstrated that proteins in conditioned media (CM) were necessary for the increase in p52 and mass spectrometry identified S100A4 and cyclophilin A (CYPA) as potential factors in CM necessary for induction of p52. The requirement of these proteins in CM for induction of p52 was confirmed using depletion and supplementation studies. In addition, we found that activation of STAT3 signaling was required for the increase in p52. Finally, genome wide ChIP-sequencing analysis confirmed that there is an increase in p52 chromatin enrichment with senescence and identified several downstream factors whose expression is regulated by increased p52 binding.

Conclusions: These results demonstrate that p52 nuclear translocation is increased in senescent cells by factors in conditioned media and that mature p52 induces cellular senescence. The data are consistent with the prior observation that p52 is elevated in aged tissue and support the hypothesis that p52 contributes to organismal aging.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981737PMC
http://dx.doi.org/10.1186/s13578-022-00779-6DOI Listing

Publication Analysis

Top Keywords

increase p52
28
p52
20
cellular senescence
12
increase
9
senescent cells
8
aged tissue
8
p52 promotes
8
mature p52
8
p52 nuclear
8
nuclear translocation
8

Similar Publications

IL-1β stimulates a novel axis within the NFκB pathway in endothelial cells regulated by IKKα and TAK-1.

Biochem Pharmacol

December 2024

Strathclyde Institute for Pharmacy and Biomedical Sciences, University of Strathclyde, 161 Cathedral Street, Glasgow, G4 0RE, Scotland, UK. Electronic address:

In this study we examined the activation of the non-canonical NFκB signalling pathway in endothelial cells. In HUVECs, LIGHT stimulated a delayed induction of serine 866/870 p100 phosphorylation linked to p52 NFκB formation. Surprisingly, the canonical ligand, IL-1β, stimulated a rapid phosphorylation or p100 which was not associated with p52 formation.

View Article and Find Full Text PDF

Reduced OTUD7B expression correlates with poor prognosis in PTCL via non-canonical NF-κB.

Int J Hematol

December 2024

Department of Cellular and Genetic Medicine, School of Basic Medical Sciences, Fudan University, Shanghai, 200032, China.

Article Synopsis
  • Peripheral T cell lymphoma (PTCL) is aggressive with poor outcomes, increasing the need for effective biomarkers for treatment strategies.
  • The study found that lower levels of OTUD7B in PTCL patients correlated with shorter progression-free and overall survival, suggesting its importance as a prognostic marker.
  • Additionally, treatments combining 5-azacytidine or cytarabine with doxorubicin showed enhanced anti-lymphoma effects, potentially improving PTCL therapy outcomes.
View Article and Find Full Text PDF

Identification and study of new NF-κB-inducing kinase ligands derived from the imidazolone scaffold.

Arch Pharm (Weinheim)

November 2024

Departamento de Nefrología e Hipertensión, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain.

Chronic kidney disease (CKD) is a growing health concern, projected to be a major cause of death by 2040, due to an increasing risk of acute kidney injury (AKI). Systems biology-derived data suggest that the unmet need for an orally available drug to treat AKI and improve CKD outcomes may be addressed by targeting kidney inflammation and, specifically, nuclear factor κB-inducing kinase (NIK), a key signaling molecule that activates the noncanonical nuclear factor κB (NF-κB) pathway. We have prepared and identified a small family of imidazolone derivatives that bind NIK and inhibit the noncanonical NF-κB activation pathway.

View Article and Find Full Text PDF

Intrinsic functional defects in B cells of patients with NFKB2 mutations.

Clin Exp Immunol

October 2024

Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

Article Synopsis
  • * The study focused on five patients with specific NFKB2 mutations, demonstrating that those with frameshift mutations had truncated proteins and significant immune system deficiencies, such as B-cell lymphopenia and hypogammaglobulinemia.
  • * Laboratory tests showed that naïve B cells from some patients had decreased survival and activation abilities, highlighting intrinsic defects in their B cells due to NFKB2 mutations, even though class switch recombination remained unaffected.
View Article and Find Full Text PDF

Galectin-9 activates host immune response and improve immunoprotection of Onychostoma macrolepis against Aeromonas hydrophila infection.

Fish Shellfish Immunol

November 2024

College of Animal Science and Technology, Northwest A&F University, Yangling, 712100, Shaanxi, China. Electronic address:

Galectin-9 (Gal-9) belongs to a family of the glycan-binding proteins (GBPs) and is known to restrict bacterial activity via interacting with pathogen associated molecular pattern (PAMPs). However, the underlying immune mechanism of endogenous Gal-9 on fish against bacterial infection is still unclear. In this study, effects of Gal-9 from Onychostoma macrolepis (OmGal-9) on expression of immune-related genes were measured by HEK293T.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!